"Entrepreneurship is the last refuge of the trouble making individual." Natalie Clifford Barne American Writer Extera Facilitates Partnership Deal Between Exalenz Biosciences and Metabolic Solutions Inc (Israeli press/Hebrew/PDF) Lothar Koob (GP) In The Press: "FDA Clears Nexstim's Navigated Brain Stimulation" Lothar Koob Joins EDGE Medical Devices Board of Directors Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation Extera is supporting strategy and commercialization efforts of a leading Israeli life science company (Israeli press/Hebrew/PDF) Extera Capital To Supply HC Expansion Funds Extera Partners to moderate a panel at the MIT Sloan BioInnovations Conference in Cambridge Massachusetts Extera Partners Creates Extera Capital to Fund Underserved Life Science Companies Dr. Robert Parnell Joins Extera Partners to Expand Its Diagnostics Advisory Capabilities Innovations in Breast Imaging: (Highlighting Extera's work with Karmanos Cancer Institute) (PDF) Extera Partners Q4 2007 Newsletter Extera Partners to Speak at the Global Healthcare Investing Conference in Cleveland, OH XCounter AB (AIM: XCT) Appoints General Partner Lothar Koob as Executive Chairman Life Science Development LLC facilitates a strategic deal between Biosignal Ltd.(ASX:BOS) and a major European medical device company (PDF) Genetic Diagnostics Technologies Corp. Announces Engagement of Life Science Development LLC Novelos Therapeutics Inc. (OTCBB: NVLT), obtains FDA Fast Track Designation (PDF) Life Science Development is featured in the Globes, the leading business news paper in Israel (PDF) Alchemia Limited ((ASX: ACL), is named Queensland's "Smartest" company (PDF)

© 2007 Extera Partners. All rights reserved. Design by Tien-Yi Lee.